IPEL has been sold to Lanxess
Client: Itibanyl Produtos Especiais Ltda (IPEL)
Client Location: Brazil
Target: Itibanyl Productos Especiais Ltda (IPEL)
Target Location: Brazil
Buyer: Lanxess AG
Buyer Location: Germany
Target Description: IPEL is a family-owned specialty chemical company.
Meet our Senior Team
My approach with our bankers and clients is to listen, pay attention to detail, anticipate and keep an eye on the big picture.
Managing Director | CEO BrazilSão Paulo
View More Transactions
Lincoln International is pleased to announce that SIGOS, LLC, a portfolio company of Thoma Bravo, LLC, has been acquired by Mobileum, Inc., a portfolio company of Audax Management Company, LLC
Lincoln International is pleased to announce that North Castle Partners has made a strategic investment in Sparx Hockey
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ), a leading independent third-party administrator (TPA) of self-funded medical plans, has received an investment from Abry Partners LP, a private investment firm focused on investing in and building market-leading middle market businesses
Lincoln International represents management in its majority sale of Fish is Life to NTC Wismettac Europe B.V.